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TRPM8 is a polymodal, nonselective cation channel activated by cold temperature and cooling agents that plays a critical role in the
detection of environmental cold. We found that TRPM8 is a pharmacological target of tacrolimus (FK506), a macrolide immunosuppres-
sant with several clinical uses, including the treatment of organ rejection following transplants, treatment of atopic dermatitis, and dry
eye disease. Tacrolimus is an inhibitor of the phosphatase calcineurin, an action shared with cyclosporine. Tacrolimus activates TRPM8
channels in different species, including humans, and sensitizes their response to cold temperature by inducing a leftward shift in the
voltage-dependent activation curve. The effects of tacrolimus on purified TRPM8 in lipid bilayers demonstrates conclusively that it has a
direct gating effect. Moreover, the lack of effect of cyclosporine rules out the canonical signaling pathway involving the phosphatase
calcineurin. Menthol (TRPM8-Y745H)- and icilin (TRPM8-N799A)-insensitive mutants were also activated by tacrolimus, suggesting a
different binding site. In cultured mouse DRG neurons, tacrolimus evokes an increase in intracellular calcium almost exclusively in
cold-sensitive neurons, and these responses were drastically blunted in Trpm8 KO mice or after the application of TRPM8 antagonists.
Cutaneous and corneal cold thermoreceptor endings are also activated by tacrolimus, and tacrolimus solutions trigger blinking and
cold-evoked behaviors. Together, our results identify TRPM8 channels in sensory neurons as molecular targets of the immunosuppres-
sant tacrolimus. The actions of tacrolimus on TRPM8 resemble those of menthol but likely involve interactions with other channel
residues.
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Introduction
Macrolide immunosuppressants are a class of natural com-
pounds sharing a macrolide-like structure and potent immuno-
suppressive activity in vitro and in vivo. Tacrolimus (TAC), also
known as FK506, is the best-known drug in this group. Originally
isolated from the bacteria Streptomyces tsukubaensis, TAC binds
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Significance Statement
TRPM8 is a polymodal TRP channel involved in cold temperature sensing, thermoregulation, and cold pain. TRPM8 is also
involved in the pathophysiology of dry eye disease, and TRPM8 activation has antiallodynic and antipruritic effects, making it a
prime therapeutic target in several cutaneous and neural diseases. We report the direct agonist effect of tacrolimus, a potent
natural immunosuppressant with multiple clinical applications, on TRPM8 activity. This interaction represents a novel neuroim-
mune interface. The identification of a clinically approved drug with agonist activity on TRPM8 channels could be used experi-
mentally to probe the function of TRPM8 in humans. Our findings may explain some of the sensory and anti-inflammatory effects
described for this drug in the skin and the eye surface.
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to FKBP12, a protein of the immunophilin family, and this com-
plex acts as a potent calcineurin inhibitor, a calcium/calmodulin-
dependent Ser/Thr phosphatase. Calcineurin inhibition results
in the block of T-cell activation and differentiation, thus inhibit-
ing the release of inflammatory cytokines (for review, see Rusnak
and Mertz, 2000). TAC is widely used for the prevention of trans-
plant/graft rejection. Cyclosporine is a fungal cyclic undecapep-
tide, structurally unrelated to TAC but sharing similar inhibitory
effects on the calcineurin pathway, and also used in preventing
organ rejection. Other clinical applications of TAC include their
topical use in several skin disorders, including atopic dermatitis,
psoriasis, and pruritus (Beck, 2005; Stull et al., 2016), and in
ophthalmology for the treatment of various diseases, including
Sjögren’s syndrome, allergic conjunctivitis, and dry-eye disease
(DED) symptoms (Fukushima et al., 2014; Wan and Dimov,
2014).
In addition to its immunosuppressive actions, previous stud-
ies suggested possible direct effects of TAC on sensory nerve end-
ings (Senba et al., 2004). Another study postulated the activation
and subsequent desensitization of TRPV1 channels by TAC
(Pereira et al., 2010). Nevertheless, the mechanisms involved in
TAC effectiveness for the treatment of cutaneous disorders and
DED, and its molecular targets in these tissues, are presently
unclear.
Here we describe the agonistic effect of TAC, but not cyclo-
sporine, on the cold- and menthol-activated TRPM8 channel
(McKemy et al., 2002; Peier et al., 2002). This polymodal, nonse-
lective cation channel is expressed in the soma of a subset of
small-diameter primary sensory neurons and their peripheral
terminals (Takashima et al., 2007; Dhaka et al., 2008). Apart from
cold and cooling compounds (e.g., menthol and icilin) (McKemy
et al., 2002; Bödding et al., 2007; Zakharian et al., 2010), TRPM8
is also activated by the membrane lipid phosphatidylinositol 4,5-
bisphosphate (PIP2) (Liu and Qin, 2005; Rohács et al., 2005).
In addition to its well-established role in the activation of
low-threshold thermoreceptors, responsible for the sensation of
innocuous cold (Bautista et al., 2007; Dhaka et al., 2007), other
studies showed the involvement of TRPM8 channels in noxious
cold sensations and cold allodynia (for review, see Almaraz et al.,
2014). TRPM8 channels also play a major role in the electrical
activity of cold-sensitive corneal endings and have been impli-
cated in the mechanisms of tearing and blinking (Parra et al.,
2010; Robbins et al., 2012; Quallo et al., 2015), important players
in the pathophysiology of DED (Belmonte et al., 2017). Other
studies demonstrated the role of TRPM8 in menthol-induced
analgesia during acute and inflammatory pain (Liu et al., 2013). A
functional, truncated isoform of TRPM8 is expressed in endo-
plasmic reticulum of skin keratinocytes where it plays an impor-
tant role in epidermal homeostasis (Bidaux et al., 2015). Recently,
TRPM8 activation was shown to evoke intense itch relief in pa-
tients and animal models of chronic itch (Ständer et al., 2017;
Palkar et al., 2018).
The involvement of TRPM8 in these and other common pa-
thologies, including migraine, has made it a relevant therapeutic
target, triggering major efforts in the identification of novel
small-molecule modulators of TRPM8 channels (Moran and
Szallasi, 2018). The list of selective antagonists has grown rapidly
(for review, see Almaraz et al., 2014), and some have shown clin-
ical efficacy in humans (Andrews et al., 2015). After the identifi-
cation of menthol, several compounds where shown to have
agonist activity on TRPM8, but most of them display cross phar-
macology with other ion channels, especially with other members
of the TRP family (Macpherson et al., 2006).
Here, we identified TAC, a clinically approved drug, as a
TRPM8 agonist with direct gating of the channel. In addition, our
characterization of TAC effects on TRPM8 mutants revealed im-
portant differences in its agonist effects compared with the ca-
nonical activator menthol, illuminating some novel aspects of
TRPM8 function as a polymodal sensory receptor.
Materials and Methods
Animals. Studies were performed on young adult (1– 4 months old) mice
of either sex. Mice were bred at the Universidad Miguel Hernández An-
imal Research Facilities (ES-119-002001) and kept in a barrier facility
under 12 h:12 h light/dark cycle with food and water ad libitum. WT
animals were of the C56Bl6/J strain. All experimental procedures were
performed according to the Spanish Royal Decree 1201/2005 and the
European Community Council directive 2010/63/EU, regulating the use
of animals in research.
Two transgenic mouse lines were used for calcium imaging experi-
ments and electrophysiological recordings on DRG cultures. In
Trpm8 BAC-EYFP mice, the fluorescent protein YFP is expressed under
the Trpm8 promoter (Morenilla-Palao et al., 2014). For experiments
with Trpm8 KO mice, we used a transgenic knockin line, Trpm8EGFPf,
in which the Trpm8 locus was disrupted and EGFP was inserted in
frame with the Trpm8 start codon (Dhaka et al., 2007). Homozygous
mice (Trpm8EGFPf/EGFPf) are null for TRPM8. As previously described,
to enhance EGFPf expression, the lox-P-flanked neomycin selection cas-
sette introduced into the Trpm8 locus during the generation of the trans-
gene was excised (Dhaka et al., 2008). Both transgenic lines allowed the
identification of TRPM8-expressing cells by the expression of YFP or
GFP fluorescence. Moreover, Trpm8 EGFPf/ (i.e., hemizygous) allowed
recordings from GFP() neurons with one functional copy of TRPM8.
The genotype of transgenic mice was established by PCR.
Culture and transfection of mammalian cell lines. Human embryonic
kidney 293 cells (HEK293) were maintained in DMEM plus Glutamax,
supplemented with 10% FBS and 1% penicillin/streptomycin, incubated
at 37°C in a 5% CO2 atmosphere. HEK293 cells were plated in 24-well
dishes at 2  10 5 cells/well and transiently transfected with Lipo-
fectamine 2000 (Thermo Fisher Scientific). When necessary, we cotrans-
fect the cells with 1 g of TRPM8 channel plasmid (from different
species) and 0.5 g of GFP plasmid. For the transfection, 2 l of Lipo-
fectamine 2000 was mixed with the DNA in 100 l of OptiMem (Thermo
Fisher Scientific), a reduced serum media. Electrophysiological and
calcium imaging recordings took place 24 –36 h after transfection. The
evening before the experiment, cells were trypsinized (0.25% trypsin-
EGTA) and reseeded at lower density in 12-mm-diameter glass coverslips
previously treated with poly-L-lysine.
The expression vectors used and their source were as follows: mouse
TRPM8 (NM_134252) in pcDNA5, kindly provided by Ardem Patapou-
tian (Scripps Research Institute), was used as a WT TRPM8. A menthol-
insensitive mutant (Y745H) and an icilin-insensitive mutant (N799A)
were obtained by site-directed mutagenesis from this WT construct as
described previously (Mälkiä et al., 2009). Point mutations were con-
firmed by sequencing of the plasmids and posterior analysis with Laser-
gene software (DNASTAR). Human TRPM8 in pcDNA3 (Veit Flockerzi,
Saarland University), human TRPA1 in pCMV6-AC-GFP vector (Vikto-
rie Vlachova, Czech Academy of Sciences), mouse mycTRPM3-IRES-
GFP (Stefan Phillip, Saarland University), and rat TRPV1 in pcDNA3
(Davis Julius, University of California–San Francisco) were also tran-
siently transfect in HEK293 cells using the same techniques.
HEK293 cells stably expressing rat TRPM8 channels (CR#1 cells)
(Brauchi et al., 2004) were cultured in DMEM containing 10% of FBS,
1% penicillin/streptomycin, and 450 g/ml geneticin (G418).
DRG cultures. Adult mice of either sex (1– 4 months) were anesthetized
with isoflurane and decapitated. The spinal cord was isolated, and DRGs
were dissected out from all spinal segments and maintained in ice-cold
HBSS solution. After isolation, DRGs were incubated with collagenase
Type XI (Sigma-Aldrich) and dispase II for 30 – 45 min in Ca 2- and
Mg 2-free HBSS medium at 37°C in 5% CO2. Thereafter, DRGs were
mechanically dissociated by passing 15–20 times through a 1 ml pipette
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tip and filtered through a 70 m nylon filter. Neurons were harvested by
centrifugation at 1200 rpm during 5 min. The resultant pellet was resus-
pended in MEM supplemented with 10% FBS, 1% MEM-vit, and 1%
penicillin/streptomycin and plated on poly-L-lysine-coated glass cover-
slips. Electrophysiological and calcium-imaging recordings were per-
formed after 12–36 h in culture.
Fluorescence Ca2 imaging. Ratiometric calcium imaging experiments
were conducted with the fluorescent indicator fura-2 (Thermo Fisher
Scientific). DRG neurons or HEK293 cells were incubated with 5 M
fura-2 AM and 0.2% pluronic (Thermo Fisher Scientific) for 45 min at
37°C in standard extracellular solution. Fluorescence measurements
were obtained on an inverted microscope (Leica Microsystems) fitted
with an Imago-QE Sensicam camera (PCO). Fura-2 was excited at 340
and 380 nm (excitation time 60 ms) with a rapid switching monochro-
mator (TILL Photonics) or an LED-based system (Lambda OBC, Sutter
Instruments). Mean fluorescence intensity ratios (F340/F380) were dis-
played online with TillVision software (TILL Photonics) every 2 s. The
standard bath solution contained the following (in mM): 140 NaCl, 3
KCl, 2.4 CaCl2, 1.3 MgCl2, 10 HEPES, and 10 glucose, and was adjusted
to a pH of 7.4 with NaOH (290 mOsm/kg). Calcium imaging and elec-
trophysiological recordings were performed at a basal temperature of
33  1°C. Before the start of the experiment, an image of the microscopic
field was obtained with transmitted light and under 460 nm excitation
wavelength, to identify fluorescent cells.
Responses to agonists were calculated by measuring the peak ratio
values, after subtracting the mean baseline fluorescence ratio during the
15 s previous to agonist application. Responses were scored as positive if
the increase in fluorescence (fura-2 ratio) was 0.08.
Electrophysiology in cultured cells. Whole-cell voltage- and current-
clamp recordings were obtained from mice DRG neurons or transiently
transfected HEK293 cells with borosilicate glass patch-pipettes (Sutter
Instruments, 4 – 8 M resistance) and were performed simultaneously
with temperature recordings. Signals were recorded with an Axopatch
200B patch-clamp amplifier (Molecular Devices) and digitized through a
Digidata 1322A (Molecular Devices). Stimulus delivery and data acqui-
sition were performed using pCLAMP9 software (Molecular Devices).
For neuronal recordings, we used the standard bath solution (see
above) at a basal temperature of 33°C. The intracellular solution con-
tained the following (in mM): 115 K-gluconate, 25 KCl, 9 NaCl, 10
HEPES, 0.2 EGTA, 1 MgCl, 1 Na2GTP, and 3 K2ATP, adjusted to pH 7.35
with KOH (280 mOsm/kg). In voltage-clamp recordings, amplifier gain
was set at 1, sampling rate was set to 10 kHz, and the signal was filtered
at 2 kHz. Neurons were voltage-clamped at a potential of 60 mV. For
current-clamp recordings, gain was set at 10, acquisition rate was 50
kHz, and the signal was filtered at 10 kHz. Once in the whole-cell config-
uration, resting membrane potential was measured. In neurons that fired
action potentials at rest, a small DC current was injected to bring the cell
to 	55 mV.
For electrophysiological experiments in HEK293 cells, to minimize
desensitization of TRPM8 responses, a calcium-free extracellular solu-
tion was used (in mM as follows): 144.8 NaCl, 3 KCl, 1 EGTA, 1.3 MgCl2,
10 HEPES, and 10 glucose (290 mOsm/kg, pH adjusted to 7.4 with
NaOH). The intracellular solution for HEK293 recordings was (in mM as
follows): 135 CsCl, 2 MgCl2, 10 HEPES, 1 EGTA, 5 Na2ATP, and 0.1
NaGTP, adjusted to pH 7.4 with CsOH (280 mOsm/kg). Recordings
were performed at a basal temperature of 33  1°C, except for the exper-
iments in which opening and inactivation kinetics were studied in which
temperature was set at 23  1°C.
After a Giga-ohm seal was formed, and the whole-cell configuration
was established, cells were voltage-clamped at a potential of 60 mV, and
voltage ramps from 100 to 150 mV (0.62 mV/ms) were applied at 3 s
intervals (0.33 Hz). For the experiments examining the opening and
inactivation kinetics, 100 ms duration voltage steps were applied (from
80 to 240 mV) from a holding potential of 80 mV. The currents were
acquired at 10 kHz, filtered at 2 kHz, The ramps were analyzed with
WinASCD software package (Prof. G. Droogmans, Laboratory of Physi-
ology, KU Leuven).
Temperature stimulation. Glass coverslip pieces with cultured cells
were placed in a microchamber and continuously perfused with solu-
tions warmed at 32°C-34°C. The temperature was adjusted with a Peltier
device (CoolSolutions) placed at the inlet of the chamber, and controlled
by a feedback device (Reid et al., 2001). Cold sensitivity was investigated
with a temperature drop to 	18°C. The bath temperature was monitored
with an IT-18 T-thermocouple connected to a Physitemp BAT-12 micro-
probe thermometer (Physitemp Instruments) and digitized with an
Axon Digidata 1322A AD converter running Clampex 9 software (Mo-
lecular Devices).
Preparation and purification of the TRPM8 protein from HEK293 cells.
HEK293 cells stably expressing rat myc-tagged TRPM8 were grown to
70%– 80% confluence, washed, and collected with PBS. Cells were har-
vested and resuspended in NCB buffer, containing 500 mM NaCl, 50 mM
NaH2PO4, 20 mM HEPES, 10% glycerol, pH 7.5, with addition of 1 mM of
protease-inhibitor PMSF, 5 mM -mercaptoethanol. Thereafter, cells
were lysed by the freeze-thawing method and centrifuged at low speed to
remove cell debris and DNA. The supernatant was further centrifuged at
40,000  g for 2.5 h, and the pellet resuspended in NCB buffer with
addition of a protease inhibitor mixture (Roche Diagnostics), 0.1% Non-
idet P40 (Roche Diagnostics), and 0.5% dodecyl-maltoside (DDM) (Cal-
biochem). The suspension was incubated overnight at 4°C on a shaker
with gentle agitation and then centrifuged for 1 h. at 40,000  g. Further,
the TRPM8 protein was purified by immunoprecipitation with anti-
Myc-IgG conjugated to A/G-protein magnetic beads (Thermo Fisher
Scientific), following the procedure provided by the manufacturer. All
steps of purification were performed at 4°C. For the planar lipid bilayers
experiments, the protein was eluted with NCB-elution buffer, containing
0.03% lauryl maltose neopentyl glycol (LMNG) and Myc-peptide
(150 g/ml).
Planar lipid bilayer measurements. Planar lipid bilayers measurements
were performed as previously described (Zakharian et al., 2010; Asuthkar
et al., 2015). Planar lipid bilayers were formed from a solution of syn-
thetic 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine and 1-palmitoyl-
2-oleoyl-glycero-3-phosphoethanolaminein (Avanti Polar Lipids) in a
3:1 ratio in n-decane (Sigma-Aldrich). The solution was used to paint a
bilayer in an aperture of 	150 m diameter in a Delrin cup (Warner
Instruments) between symmetric aqueous bathing solutions of 150 mM
KCl, 0.2 mM MgCl2, 1 M CaCl2, 20 mM HEPES, pH 7.4, at 22°C. All lipid
bilayer experiments were performed in the presence of PIP2, unless spe-
cifically omitted as indicated: 2.5 M DiC8-PIP2 (Cayman Chemical)
dissolved in water was added to both compartments. All salts were ultra-
pure (99%) (Sigma-Aldrich). Bilayer capacitances were in the range of
50 –75 pF. After the bilayers had been formed, the TRPM8 protein from
the micellar suspension (20 ng/ml) was added by painting to both com-
partments. Unitary currents were recorded with an integrating patch-
clamp amplifier (Axopatch 200B, Molecular Devices). The trans solution
(voltage command side) was connected to the CV 201A head stage input,
and the cis-solution was held at virtual ground via a pair of matched
Ag-AgCl electrodes. Currents through the voltage-clamped bilayers
(background conductance 
 1 pS) were filtered at the amplifier output
(low pass, 3 dB at 10 kHz, 8-pole Bessel response). Data were sec-
ondarily filtered at 100 Hz through an 8-pole Bessel filter (950 TAF,
Frequency Devices) and digitized at 1 kHz using an analog-to-digital
converter (Digidata 1322A, Molecular Devices), controlled by
pClamp10.3 software (Molecular Devices). Single-channel conduc-
tance events, all points’ histograms, open probability, and other pa-
rameters were identified and analyzed using the Clampfit10.3
software (Molecular Devices).
Isolated skin nerve preparation. Extracellular recordings from single
cutaneous primary afferent axons in an isolated mouse skin-saphenous
nerve preparation were obtained following previously published proce-
dures (Roza et al., 2006; Zimmermann et al., 2009). In brief, adult male
C57BL/6J mice were killed by cervical dislocation, and the hairy skin
from either hindpaw, with the saphenous nerve attached, was dissected
free from underlying muscles and placed in a custom made Teflon re-
cording chamber with the corium side up (Zimmermann et al., 2009).
The chamber containing the preparation was continuously superfused
at a rate of 4 ml/min with oxygenated external solution consisting of the
following (in mM): 107.8 NaCl, 26.2 NaHCO3, 9.64 sodium gluconate,
7.6 sucrose, 5.55 glucose, 3.5 KCl, 1.67 NaH2PO4, 1.53 CaCl2, and 0.69
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MgSO4, which was adjusted to pH 7.4 by continuously gassing with 95%
oxygen/5% CO2. Temperature of the solution was maintained 	34°C
with a SC-20 in-line heater/cooler system, driven by a CL-100 bipolar
temperature controller (Warner Instruments).
After pulling back the perineurum with Dumont #5SF forceps, a small
bundle of fibers was aspirated into a patch-pipette connected to a high
gain AC differential amplifier (model DAM 80; World Precision Instru-
ments). A reference electrode was positioned inside the chamber. Input
signals were amplified, digitized (CED Micro1401-3; Cambridge Elec-
tronic Design) at 25 kHz and stored in the hard drive of a PC for off-line
analysis. For recording and off-line analysis, the Spike 2 software package
was used (Cambridge Electronic Design).
A small, cone-shaped piece of frozen external solution was moved
slowly over the corium side of the skin and used to identify cold spots:
brisk thermoreceptor fiber activity was evoked by the ice cone when in
the immediate vicinity of the receptive field, and this activity stopped
shortly after removing the stimulus. Cold spots identified in this way
where then isolated from the surrounding tissue with a small ABS ther-
moplastic ring, and delivery of the subsequent cold and chemical stimuli
was restricted to a circular area (5 mm diameter) of the skin. Cold stimuli
were performed with solutions flowing through a Peltier system custom-
designed to deliver a small volume of solution inside the ring isolating the
skin area. Starting from a baseline temperature of 34°C–35°C, the tem-
perature reached 	12°C in 	50 s.
In control conditions, at the baseline temperature of 34°C–35°C, cold
thermoreceptors were silent, firing action potentials during the cooling
ramp. The cold threshold was defined as the temperature corresponding
to the first spike during a cooling ramp. When chemical sensitization
led to the appearance of ongoing activity already at basal temperature,
cold threshold was taken as the mean temperature during the 60 s pre-
ceding the start of the cooling ramp. Chemical sensitivity of single fibers
was tested with consecutive applications of TAC (30 M), followed by
menthol (50 M) after a period of wash. Chemical sensitivity during
recordings at 34°C was defined as the presence of at least 20 spikes during
a period of 2 min before the cooling ramp. To explore their effects on cold
sensitivity, a cold temperature ramp was also applied in the presence of
TAC or menthol.
Extracellular recording of corneal nerve terminals. Adult C57BL/6J mice
(3– 6 months old; n  10) were killed by cervical dislocation, their eyes
extracted, mounted in a small chamber, and continuously perfused with
an oxygenated solution (	310 mOsm/kg) of the following composition
(in mM): 128 NaCl, 5 KCl, 1 NaH2PO4, 26 NaHCO3, 2.4 CaCl2, 1.3
MgCl2, and 10 D-glucose. The solution was bubbled with carbogen gas
(5% CO2 and 95% O2) and maintained at the desired temperature with a
Peltier device.
A broken patch-pipette, mounted on a micromanipulator and con-
nected to a high-gain amplifier (Neurolog NL104, Digitimer), was gently
pressed against the corneal surface to obtain extracellular recordings of
single cold-sensitive corneal nerve terminals in vitro, as described previ-
ously (Parra et al., 2010; González-González et al., 2017). Recordings
were digitized at 10 kHz and stored in a computer using a CED micro
1401 interface and Spike 2 software (both from Cambridge Electronic
Design).
The corneal surface was systematically explored with the recording
microelectrode until the isolation of spontaneous activity. Starting from
a basal temperature of 34°C, the bath temperature was lowered in a
staircase fashion to 30°C and 25°C and maintained at each level for 	3
min. After returning to 34°C, the eye was bathed in 30 M TAC and the
staircase of low temperatures repeated. Each cornea was only exposed
once to the drug.
Behavioral assessment of temperature sensitivity. Male C57BL/6J mice
(2–3 months old) were obtained from The Jackson Laboratory and bred
in house. The TRPM8 KO line was the same used in the cellular studies
and kept on a C57BL/6J background (Dhaka et al., 2007). Mice were
housed in large cages (1290D Eurostandard Type III) with food and
water ad libitum. Animals were tested between 8:30 A.M. and 11:00 A.M.
Before testing, animals were acclimatized to handling and being held in a
lightly restrained position for 30 s on a flat surface at room temperature.
For baseline measurements, each hindpaw was placed individually in
contact with the surface of a Peltier-regulated metal plate (Bioseb cold/
hot plate) set to 10°C, and the withdrawal latency was measured with a
cutoff time of 30 s (Menéndez et al., 2002). The mean of the two paws was
calculated and taken as the baseline (i.e., naive) value for each mouse.
Thereafter, each mouse received vehicle (8% ethanol, 2% Cremophor in
saline) in one of their paws and either menthol (1%) or TAC (1%) in the
other one. Solutions were injected intraplantarly in a volume of 25 l.
Animals were returned to their cages, and each paw was tested again 20
min after injections. In TRPM8 KO mice, the experiments were identical,
except that menthol was not injected in these animals. In all cases, the
experimenter was blind to the treatment when doing the measurements.
Behavioral assessment of blinking. Adult male C57BL/6J or Trpm8 /
(Dhaka et al., 2008) mice were lightly restrained, and 5 l of saline,
vehicle (8% ethanol, 2% Cremophor in saline), TAC (1%), or an hyper-
osmolar (785 mOsm/kg) solution of saline supplemented with NaCl was
applied to one eye from the tip of a graduated micropipette (Gilson
Pipetman P20). The blinking of that particular eye was recorded using a
Logitech HD webcam camera at 30 frames per second. The solutions
were then removed and the mice returned to their home cages and left
undisturbed for at least 5 h between each experiment. Each animal was
tested in morning and afternoon sessions, alternating the left and right
eyes. Recordings were replayed at slow motion on a computer screen, and
the number of blinks was counted over a 2 min period. Counting started
3 s after the application, as there were always some blinks associated with
the application of the drop. Quantification of the number of blinks was
performed independently by 2 observers on 100 videos. The correlation
coefficient (r) for both measurements was 0.996.
Behavioral assessment of tearing. Adult male C57BL/6J mice (n  10)
were anesthetized by intraperitoneal injection of a mixture of ketamine
hydrochloride (80 mg/kg, Imalgene 1000; Merial Laboratorios) and xy-
lazine hydrochloride (5 mg/kg, Rompun; Bayer Hispania). Basal tear
flow was measured in both eyes, after consecutive applications of a drop
(2 l), using a graduated micropipette (Gilson Pipetman P2), of either
saline, vehicle (8% ethanol, 2% Cremophor in saline), and TAC (1%), in
this order, using phenol red threads (Zone-Quick, Menicon Pharma).
Each solution was applied for 2 min. Thereafter, excess fluid was re-
moved using a sterile absorbent swap (Sugi Eyespear pointed tip, Ketten-
cach). After a rest period of 5 min, a phenol red thread was gently placed
between the lower lid and the bulbar conjunctiva at the nasal angle dur-
ing 1 min. To quantify the staining of the threads, the wetted length was
measured under a stereomicroscope. After 2 additional minutes, a new
solution was applied. One week later, the protocol was repeated in some
of the same animals (n  5) but applying saline solution in the three
consecutive tests.
Chemicals. TAC, also known as FK506 (LC Laboratories) was prepared
in a DMSO stock (50 mM) and was dissolved in prewarmed (50°C) con-
trol solution. When TAC was added to the external solution, a white
cloud of precipitation appeared and gentle shaking was applied until
total dissolution was obtained. Due to its poor solubility in water, a
solution of 30 M TAC was the highest concentration tested. The
stock of cyclosporine (LC Laboratories) was also 50 mM in DMSO.
Menthol (Scharlau), BCTC (4-(3-chloro-2-pyridinyl)-N-[4-(1,1-
dimethylethyl)phenyl]-1-piperazinecarboxamide; Tocris Bioscience),
AMTB (N-(3-aminopropyl)-2-[(3-methylphenyl)methoxy]-N-(2-thi-
enylmethyl)benzamide hydrochloride; Tocris Bioscience), M8-B
(N-(2-aminoethyl)-N-[[3-methoxy-4-(phenylmethoxy)phenyl]
methyl]-2-thiophenecarboxamide hydrochloride), pregnenolone
sulfate (Tocris Bioscience), allyl isocyanate (AITC; Sigma-Aldrich),
and capsaicin (8-methyl-N-vanillyl-trans-6-nonenamide; Sigma-
Aldrich) were prepared as stocks and stored at 20°C. For in vivo
experiments, a 10% (100 mg/ml) stock of TAC was prepared in 80%
ethanol, 20% Cremophor in PEG-60 Hydrogenated Castor Oil
(BASF), and diluted to 1% in saline on the day of the experiment.
The final solution had a homogeneous milky white color without
precipitations.
Experimental design and statistical analysis. To estimate shifts in the
voltage dependence of TRPM8 activation, current-voltage ( I–V) rela-
tionships obtained from repetitive (0.33 Hz) voltage ramps (100 to 150
952 • J. Neurosci., February 6, 2019 • 39(6):949 –969 Arcas et al. • Immunosuppressant Activation of TRPM8
mV, 400 ms duration) were fitted with a function that combines a linear
conductance multiplied by a Boltzmann activation term as follows:
I  G  (V  Erev)/(1  exp((V1/2  V)/dx))
where G is the whole-cell conductance, Erev is the reversal potential of the
current, V1/2 is the potential for half-maximal activation, and dx is the
slope factor. The G value obtained for a high menthol concentration (800
M) was taken as Gmax and was used for the representation of G/Gmax
curves.
For the fitting of G/Gmax curves extracted from the voltage pulses
protocol, a Boltzmann equation was used as follows:
G/Gmax  A2  (A1  A2)/(1  exp((Vm  V1/2)/dx))
where A2 is the maximal normalized conductance, A1 is the minimal
normalized conductance, Vm is the test potential, V1/2 is the potential for
half-maximal activation and dx is the slope factor.
Conductance-voltage ( G–V) curves were constructed from the I–V
curves of individual cells by dividing the evoked current by the driving
force, according to the following equation:
G  I/(Vm  Vrev)
where Vm is the testing potential and Vrev is the reversal potential of the
current.
The threshold temperatures were estimated as the first point at which
the measured signal (F340/F380 or current) deviated by at least 4 times
the SD of its baseline. All fittings were performed with the Levenberg–
Marquardt method implemented in the Origin 8.0 software. Data are
reported as mean  SEM. When comparing two means, statistical sig-
nificance ( p 
 0.05) was assessed by Student’s two-tailed t test. For
multiple comparisons of means, one-way ANOVAs were performed, fol-
lowed by Bonferroni’s post hoc analysis, using Prism version 4.00 for
Windows (GraphPad Software).
Results
TAC activates recombinant TRPM8 channels
To evaluate the agonist effect of TAC on TRPM8, we performed
intracellular Ca 2 imaging experiments on HEK293 cells stably
expressing rat TRPM8 channels. As shown in Figure 1A, B, TAC
produced a dose-dependent activation of TRPM8, with an esti-
mated EC50 of 14.1  25.9 M (n  105 cells). Due to its poor
solubility in aqueous solutions, it was not possible to test TAC at
higher concentrations. At low concentrations, the calcium
response evoked by TAC was sustained, whereas at higher con-
centrations there was some desensitization during agonist appli-
cation, similar to the results observed with other chemical
agonists of TRPM8 (e.g., menthol) (Rohács et al., 2005). No
changes in Ca 2 levels were observed when TAC was applied in
the absence of external Ca 2 (data not shown), indicating that
Ca 2 influx rather than Ca 2 release is responsible for TAC-
induced elevation in cytosolic Ca 2.
TRPM8 is activated by cold temperature (McKemy et al.,
2002; Peier et al., 2002), and menthol potentiates responses to
cold (Voets et al., 2004; Mälkiä et al., 2007). Similarly, TAC pro-
duced a dose-dependent potentiation of cold-evoked responses
in mouse TRPM8, with effects evident at 1 M and saturation at
	10 M (Fig. 1C,D). At 10 M, peak amplitude of cold-evoked
responses increased approximately fourfold with respect to re-
sponses in control (p 
 0.005) (Fig. 1D). A closer inspection of
TRPM8-evoked [Ca 2]i responses during cooling pulses re-
vealed that TAC, at concentrations of 10 –30 M, produced a
marked shift in the threshold for cold-evoked responses toward
warmer temperatures. The average shift was 	7°C for the highest
concentration tested, changing from 21.9  0.9°C in control so-
lution to 29.1  0.5°C in 30 M TAC (n  15, p 
 0.005).
We also explored the sensitivity of human TRPM8 to TAC. As
shown in Figure 1E, TAC (30 M) produced [Ca 2]i elevations in
HEK293 cells transiently expressing hTRPM8, and this activation
was not observed in untransfected cells (Fig. 1E). A summary of
the effects of TAC, menthol, and cold on hTRPM8 is shown in
Figure 1F.
In contrast to the effects of TAC, cyclosporine (30 M), a
structurally unrelated calcineurin inhibitor, had no effect on
HEK293 cells stably expressing rat TRPM8 channels (Fig. 1G,H).
Together, these results indicate that the immunosuppressant
TAC acts like a potent cold-mimetic compound on TRPM8
channels of different mammalian species by a mechanism inde-
pendent of its canonical signaling pathway.
TAC activates TRPM8 currents
In whole-cell patch-clamp recordings, application of 30 M TAC
activated robust whole-cell currents in HEK293 cells expressing
mouse TRPM8 (Fig. 2A). The I–V relationship of the TAC-
activated current showed strong outward rectification and a re-
versal potential close to 0 mV, in line with the previously
described properties of TRPM8 (Fig. 2B) (Voets et al., 2004;
Mälkiä et al., 2007). Confirming the results obtained in calcium
imaging experiments, cold-evoked inward and outward currents
were strongly potentiated in the presence of TAC (Fig. 2A,B),
leading to large inward (8.3  1.7 pA/pF cold vs 101.2  30.9
pA/pF TAC plus cold) and outward currents (437  47 pA/pF
cold vs 597  59 pA/pF TAC plus cold) (n  7, p 
 0.01) (Fig.
2C). Similar results were observed in HEK293 cells transfected
with human TRPM8. In cells expressing hTRPM8, TAC (30 M)
activated a rectifying nonselective current, and cold-evoked cur-
rents were strongly potentiated by TAC: 78.7  13.4 pA/pF
versus 121.9  18.3 pA/pF at 100 mV (n  8, p 
 0.0001) and
493  26.2 pA/pF versus 594.3  55.5 pA/pF at 100 mV (n  8,
p  0.0159).
To confirm the agonism of TAC on TRPM8 channels, we
tested the effect of AMTB, a selective TRPM8 antagonist. As
shown in Figure 2D, the responses to TAC were fully suppressed
by 10 M AMTB (352  55 pA/pF in TAC vs 16  3 pA/pF in
TAC plus AMTB) (n  6, p 
 0.01). AMTB also reduced the
voltage-dependent activation of TRPM8 at the baseline temper-
ature of 33°C. During combined application of cooling and TAC,
the blocking effect of AMTB was only partial (Fig. 2D–F).
Biophysical characterization of TAC effects on TRPM8 gating
Previous studies showed that low temperature and menthol acti-
vate TRPM8 channels by producing a shift in the voltage depen-
dence of activation toward more negative potentials (Brauchi et
al., 2004; Voets et al., 2004), whereas antagonists have the oppo-
site effect (Mälkiä et al., 2007). Recently, Janssens et al. (2016)
applied kinetic analysis to describe the mechanisms whereby
chemical ligands impact on TRPM8 channel gating, and differ-
entiated between two types of agonists: those stabilizing the open
channel (e.g., menthol) and those that cause a destabilization of
the closed state (e.g., AITC). We used mouse TRPM8 heterolo-
gously expressed in HEK293 to characterize the effects of TAC
(30 M) on voltage dependence and channel gating and com-
pared the effects of TAC, menthol, and AITC. Whole-cell record-
ings during steps from 80 to 240 mV were obtained at room
temperature (23  1°C), leading to substantial baseline activa-
tion of TRPM8. Menthol was applied at 10 M, TAC at 30 M,
and AITC at 10 mM, concentrations that gave rise to similar
steady-state TRPM8 current amplitudes. Following the sequen-
tial application of the three agonists, the voltage protocol was
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Figure 1. TAC activates recombinant TRPM8 channels and potentiates cold-evoked responses. A, Average  SEM fura-2 ratio changes in HEK293 cells stably expressing rat TRPM8 during
sequential application of TAC at different concentrations (n  105). B, Dose–response curve of TAC effects on TRPM8-expressing cells. Data have been fitted with a logistic function (EC50  14.1 
25.9 M). C, Average  SEM time course of fura-2 ratio in HEK293-expressing mouse TRPM8 during consecutive application of cold pulses in control solution (black trace, n  15) or in the presence
of increasing TAC concentrations (green trace, n  16). Bottom, Time course of the corresponding temperature ramps. In the absence of TAC, the response to cold was relatively stable, whereas in
the presence of TAC, the response to cold was strongly sensitized. Responses in individual cells have been normalized to their response to the first cooling pulse. D, Summary plot of the effect of
different doses of TAC on the amplitude of cold-evoked responses in mTRPM8 cells. **p 
 0.01 (ANOVA test in combination with Bonferroni’s post hoc test). ***p 
 0.001 (ANOVA test in
combination with Bonferroni’s post hoc test). E, Average  SEM fura-2 ratio responses to cold, TAC (30 M), and menthol (100 M) in HEK293 cells transiently transfected with human TRPM8 and
GFP. Green represents GFP() cells (n  132). Gray represents GFP() cells (n  87). F, Summary of mean responses in cells transfected with hTRPM8 (green bars) to the different agonists. Gray
represents the responses of untransfected, GFP() cells. TAC produced a significant activation of hTRPM8 (***p 
 0.001; unpaired Student’s t test). G, Average  SEM fura-2 ratio changes in
HEK293 cells stably expressing rat TRPM8 during application of two cooling ramps. For the black traces (n  25), cooling ramps were delivered in control solution. For the pink traces (n  107), the
second cooling ramp was applied in the presence of 30 M cyclosporine (CSA). H, Histogram summarizing the effects of cyclosporine on cold-evoked calcium responses during the protocol shown
in G. No significant differences were found between the cells perfused with control solution or cyclosporine (unpaired Student’s t test).
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repeated in the presence of 800 M menthol, a saturating concen-
tration, to obtain a Gmax value for TRPM8 activity.
Figure 3A shows a representative example of a family of cur-
rents recorded in a cell expressing mTRPM8 during 100 ms volt-
age steps ranging from 80 to 240 mV. The average steady-state
I–V and G–V curves for the different conditions are shown in
Figure 3B and Figure 3C, respectively. Analysis of these curves
revealed a strong leftward shift of the activation curve in the
presence of the three agonists, with a change in the voltage for
half-maximal activation (V1/2) from 153  7 mV in control to
106  10 mV in the presence of TAC (calculated from G–V) (Fig.
3D). The shift in V1/2 with respect to control conditions was
highly significant (p 
 0.0001). Menthol (10 M) and AITC (10
mM) had similar effects on V1/2 (Fig. 3D).
To characterize the effect of the different agonists on TRPM8
gating kinetics, we studied the changes in the time course of
current activation during voltage steps to 120 mV (Fig. 3E) and
their relaxation upon return to 80 mV (Fig. 3F). For a better
comparison, currents were normalized to their steady-state val-
ues. Both menthol and TAC produced a clear slowing of the
gating kinetics during depolarization to 120 mV and after the
return to 80 mV. In contrast, AITC clearly accelerates the acti-
vation kinetics (Fig. 3E), without affecting the current relaxation
kinetics upon repolarization to 80 mV (Fig. 3F). Currents in
control or during AITC application were adequately fitted with a
single exponential (data not shown). In contrast, the currents in
TAC or menthol required a double exponential. To quantify the
differences in kinetics produced by the three chemical agonists in
more detail, we compared the rise time to 95% of the initial value.
These results are shown in Figure 3G, H for the activation and
deactivation time course, respectively.
These results show that the mechanism of action of TAC on
TRPM8 gating resemble those of menthol and are different of the
AITC gating mechanism (Janssens et al., 2016).
Gating of TRPM8 by TAC in planar lipid bilayers
To test the possible direct action of TAC on TRPM8 gating, we
evaluated channel activity in a reconstituted system. The myc-
tagged rat TRPM8 protein was purified from HEK293 cells stably
expressing the channels using immunoprecipitation, and incor-
porated into planar lipid bilayers as previously described (Zakha-
rian et al., 2010). Similarly to other TRPM8 agonists (Zakharian
et al., 2010; Asuthkar et al., 2015), TAC led to TRPM8 channel
openings only in the presence of its prime gating factor, PIP2.
Incubation of TRPM8 with TAC alone (30 M) for a few hours
(2–3 h of testing) was insufficient to activate the channel (data
not shown). Similarly, PIP2 alone (2.5 M) did not induce chan-
nel openings at RT (data not shown). However, TRPM8 opened
promptly soon after the addition of 2.5 M PIP2 to TAC (Fig. 4A).
In the presence of TAC, TRPM8 exhibited outward currents with
a mean slope conductance of 	31 pS, and inward conductance of
	20 pS. The TAC-induced TRPM8 channel openings also dem-
Figure 2. TAC activates TRPM8-mediated whole-cell currents in HEK293 cells. A, Representative time course of whole-cell currents at 100 and 100 mV in HEK293 cell transiently transfected
with mTRPM8 during application of agonists. Bottom, Simultaneous recording of the bath temperature during the experiment. B, I–V relationship of responses shown in A, obtained with a 400 ms
voltage ramp from 100 to 150 mV. The color of individual traces matches the color at each particular time point in A. TAC evokes a nonselective cationic current with typical TRPM8 features and
potentiates the cold-evoked response. C, Bar histogram summarizing the mean current density values at 100 and 100 mV to the different stimuli shown in A, with the same color code. Statistical
differences were evaluated by a one-way ANOVA, followed by Bonferroni’s post hoc test. D, Representative time course of whole-cell currents at 100 and 100 mV during a protocol in which the
effect of AMTB was studied. AMTB 10 M totally abolished TAC-evoked currents. Bottom, Simultaneous recording of the bath temperature during the experiment. E, I–V relationship of responses
shown in D. The color of the I–V curves matches the colored time points in D. AMTB also blocks the voltage-dependent activation of TRPM8 at basal temperature. F, Bar histogram summarizing the
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Figure 3. Biophysical characterization of TAC effects on TRPM8 gating. A, Whole-cell TRPM8 currents in response to the indicated voltage step protocol (from 80 to 240 mV, v  40 mV) in
control conditions and in the presence of TAC (30 M), menthol (10 M), and AITC (10 mM) at 24°C. Note the variable effect of agonists on activation kinetics. B, Averaged (n  6) steady-state I–V
curves extracted from individual cells after application of Protocol A. The lines indicate the fitting to a linearized Boltzmann equation (see Materials and Methods). C, Averaged (n  6) voltage
dependence activation curves in control conditions and in the presence of the different agonists. Conductance (G) was calculated as the steady-state current divided by the driving force (Driving
force  Vtest  Erev), and normalized to the estimated maximal conductance (Gmax), which was the G value at 240 mV in the presence of 0.8 mM menthol. D, Mean (n  6) V1/2 values calculated
from fitting the individual I–V curves to the linearized Boltzmann equation (white bars) or the individual G/Gmax–V curves fitted to the Boltzmann equation (black bars). All three agonists produced
similar shifts in V1/2 values at the indicated concentrations. Statistical differences were evaluated by a one-way ANOVA, followed by Bonferroni’s post hoc test. E, Averaged TRPM8 current during a
voltage step from 80 to 120 mV, in control condition and in the presence of the different agonists. Currents were normalized to their steady-state amplitude after baseline subtraction. F,
Averaged  SEM TRPM8 deactivation kinetics at 80 mV obtained from current tails after a voltage step to 120 mV (box bounded by dotted line in E), in control condition and in the presence of
the different agonists. The current was normalized to the maximum value, and baseline was subtracted. G, Mean values of the current activation time course, measured from baseline to 95%
amplitude, for voltage steps to 120 mV. H, Mean values of current deactivation time course at80 mV, measured from baseline to 95% amplitude, following a voltage step to 120 mV. F, G, Statistical
differences were evaluated with a one-way ANOVA, followed by Bonferroni’s post hoc test. *p 
 0.05, **p 
 0.01, ***p 
 0.001.
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onstrated a distinct subconductance state of 	14 pS (Fig. 4A,B).
In addition to the differences in conductance for currents flowing
in the inward or outward direction, an outward rectification was
also evident in open probability (Po) (Fig. 4C). Next, we tested the
effect of a specific TRPM8 antagonist on TAC-induced channel
activity. As shown in Figure 4D, E, the TRPM8 inhibitor M8-B
essentially eliminated channel openings. Together, these results
establish a direct agonistic action of TAC on TRPM8 channels,
and also demonstrate the requirement of its activity on PIP2.
TAC activates the menthol-insensitive TRPM8-Y745H
mutant but fails to potentiate its cold response
A single tyrosine residue (Y745), located on transmembrane seg-
ment 1 according to recent Cryo-EM structural analysis (Yin et
al., 2018), is essential for the activating actions of menthol on
TRPM8 channels (Bandell et al., 2006; Mälkiä et al., 2009). These
mutant channels are completely insensitive to menthol but retain
the normal responsiveness to cold and voltage exhibited by WT
channels.
Using calcium imaging, we found that TAC activates mouse
TRPM8-Y745H (Fig. 5A,B). On average, the amplitude of the
[Ca 2]i elevation after application of 30 M TAC, normalized to
the response to a cold ramp in control conditions, was 0.20 
0.008 in WT channels (n  66) compared with 0.17  0.007 in
TRPM8-Y745H (n  38, p 
 0.05). Remarkably, despite a nor-
mal response to cold or TAC, the TRPM8-Y745H mutant showed
no potentiation of the cold response by TAC (ratio of TAC plus
cold/cold  1.09  0.05). In contrast, the WT channel showed a
strong potentiation (1.4  0.08) (Fig. 5B, p 
 0.01).
To confirm these differences, we examined the effects of TAC
on whole-cell currents in WT and mutant channels (Fig. 5C). The
current generated by TAC was normalized to the cold response
evoked in control conditions in the same cell, at a potential of 100
mV. On average, TAC current was 0.27  0.04 in WT channels
and 0.30  0.04 in the Y745H mutant, confirming that the
TRPM8-Y745H mutants maintain their normal sensitivity to
TAC. In the same cells, menthol (100 M) had no effect, as ex-
pected for the Y745H mutant (data not shown). Moreover,
whole-cell recordings confirmed that the potentiation of the
cold-evoked response by TAC was absent in the Y745H mutant
(WT ratio  1.39  0.05 vs TRPM8-Y745H ratio  0.83  0.09)
(Fig. 5D).
Next, we explored TAC sensitivity in the TRPM8-N799A mu-
tant. This residue was shown to mediate responses to icilin, a
different TRPM8 agonist (Chuang et al., 2004). TRPM8-N799A
mutants behaved like TRPM8 WT channels, with normal re-
sponses to TAC and the potentiation of the cold response (Fig.
5C,D), suggesting that the effects of TAC on TRPM8 do not
involve the icilin-binding site.
These results suggest a mode of action of TAC independent of
the putative menthol and icilin binding sites and unveil the im-
portance of the Y745 residue in the allosteric coupling between
cold and TAC activation of TRPM8.
Effects of TAC on other thermoTRP channels
Next, we tested the effects of TAC on other thermally sensitive
TRP channels (Dhaka et al., 2006). As shown in Figure 6A, TAC
(30 M) had no activating effect on rat TRPV1 or mouse TRPM3.
Figure 4. TAC activates purified TRPM8 in planar lipid bilayers. A, Representative single-channel recordings of TRPM8 obtained at 100 mV and 100 mV showing the activation with 30 M TAC
in the presence of 2.5 M PIP2. B, I–V curve of TRPM8 single-channel current during TAC activation at different membrane potentials, showing the main conductance of outward and inward currents
(green trace), and a lower subconductance state (gray trace). C, Bar graph represents open probability (Po) values at 100 and 100 mV in the presence of TAC and PIP2. Data represent mean  SEM
from 13 experiments; number of events  28,935. Po was significantly higher at 100 mV (***p 
 0.001, paired Student’s t test). D, Representative current traces demonstrating inhibition of
TAC-induced TRPM8 activity with M8-B (20 M). TRPM8 was activated with 30 M TAC in the presence of 2.5 M PIP2. Traces were obtained at 100 mV. E, Bar graph summarizing the inhibition
produced by M8-B on Po. Data represent mean  SEM from four experiments (***p 
 0.001, paired Student’s t test).
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In contrast, the same concentration of TAC activated human
TRPA1, with a slowly rising [Ca 2]i response. The activating
effects of TAC on TRPA1 were more modest than those produced
by its canonical agonist AITC (Fig. 6B). We noticed that applica-
tion of TAC produced a modest inhibition of basal calcium levels
in cells expressing TRPV1 or TRPM3, suggesting some inhibitory
effect on background activity at this temperature (i.e., 34°C). The
effects of TAC on recombinant TRPM8 and TRPA1 channels
motivated a deeper characterization of its action on primary sen-
sory neurons.
TAC activates TRPM8-expressing cold-sensitive neurons and
potentiates their cold response
TRPM8-expressing neurons represent only a small fraction of all
DRG neurons (McKemy et al., 2002; Takashima et al., 2007;
Dhaka et al., 2008). We used a BAC-transgenic mouse expressing
enhanced YFP under the Trpm8 promoter, Trpm8 BAC-EYFP
(Morenilla-Palao et al., 2014) and intracellular Ca 2 imaging
to identify TRPM8-expressing neurons in DRG cultures. Con-
firming our previous finding in this transgenic mouse line
(Morenilla-Palao et al., 2014), most YFP() neurons were
Figure 5. TAC activates the menthol- and the icilin-insensitive TRPM8 mutants. A, Averaged  SEM fura-2 ratio fluorescence of mouse TRPM8-transfected HEK293 cells during cooling, TAC (30
M) and the combined application of TAC and cooling. Records have been baseline-subtracted and the average trace normalized to the initial response to cold. Top to bottom, Calcium responses of
WT TRPM8, the menthol-insensitive TRPM8 –Y745H mutant, and a representative recording of the temperature time course in the chamber during the recording. B, Histogram of mean response
amplitudes to the different stimuli, normalized to the initial cold response. Note the lack of potentiation of the cold-evoked response by TAC in the menthol-insensitive mutant. Statistical differences
were evaluated by an unpaired Student’s t test. C, Representative traces of whole-cell recordings exploring the effect of cold and TAC in two different TRPM8 mutants. Top to bottom, Currents,
measured at 100 and 100 mV, in WT mouse TRPM8, the menthol-insensitive TRPM8 –Y745H mutant, and the icilin-insensitive TRPM8 –N799A mutant. Bottom, Representative recording of the
temperature change in the chamber during the protocol. D, Histogram of the average current values to the different agonists in TRPM8 WT and the different mutants during the protocol shown in
C. For each cell, current responses were normalized to the initial cold-evoked response. Statistical differences for the response to each agonist in the different TRPM8 constructs were evaluated with
a one-way ANOVA, followed by Bonferroni’s post hoc test. *p 
 0.05, **p 
 0.01.
Figure 6. TAC activates human TRPA1 channels. A, AveragedSEM fura-2 fluorescence ratio of HEK292 cells transfected with human TRPA1 (blue trace), rat TRPV1 (black trace), or mouse TRPM3
(green trace) during applications of TAC (30 M) and their canonical agonists capsaicin (100 nM), AITC (50 M), and pregnenolone sulfate (PS, 50 M). B, Bar histogram summarizing the effect of
TAC or the canonical agonists, capsaicin, AITC, or PS, on fura-2 fluorescence ratio. Individual records have been baseline-subtracted. TAC produced a significant elevation in [Ca 2]i in TRPA1-
transfected cells compared with TRPV1- or TRPM3-transfected cells (***p 
 0.001, one-way ANOVA followed by Bonferroni’s post hoc test). ***p 
 0.001.
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Figure 7. TAC activates cold-sensitive neurons selectively. A, Ratiometric [Ca 2] measurement from fura-2 loaded cultured DRG neurons in Trpm8 BAC-EYFP mice. Two cold-sensitive neurons
(blue and magenta traces) increased their [Ca 2] level during the cooling ramp. The same neurons also responded to 30 M TAC, and their response to cold was potentiated. The cold-insensitive
neuron (orange trace) did not respond to any of these stimuli. B, Representative image of a DRG culture from a Trpm8 BAC-EYFP mouse. A, Traces correspond to the neurons marked with the same
colored asterisk: orange for YFP(), blue and magenta for YFP(). Three additional YFP() neurons, marked with blue arrowheads, also responded to cold and TAC. Scale bar, 20 m. C, Venn
diagram showing the strong overlap between YFP() neurons (green, n  37), the response to cooling (cyan, n  36), and the response to TAC (blue, n  31). In this sample, none of the YFP()
neurons (n  130) responded to TAC. D, Bar histogram showing the average amplitude of the responses to cold, to TAC, and to cold in the presence of TAC. Amplitudes were similar for cold and TAC,
whereas the responses to cold were significantly higher in the presence of TAC. One-way ANOVA for repeated measures followed by Bonferroni’s post hoc test. E, Correlation between amplitude of
cold- and TAC-evoked responses in individual DRG neurons. Black dotted lines indicate the threshold amplitude established for considering a positive response. Blue points represent the neurons that
responded to cold and TAC (n  31). Cyan points represent the neurons that responded to cold but did not respond to TAC (n  5). Note the small cold-evoked response in neurons unresponsive to
TAC. Gray point represents the single YFP() neuron that did not respond to cold or TAC. The linear fit to the blue points (red line) yielded a correlation coefficient (r 2) of 0.42. F, Representative trace
of fura-2 ratio fluorescence in a DRG neuron during three consecutive cooling ramps. Note the strong, reversible potentiation of the cold-evoked response in the presence of 10 M TAC. Red numbers
indicate the temperature at which the measured signal (F340/F380) deviated by at least 4 times the SD of its baseline (i.e., temperature threshold). G, Bar histogram summarizing the effect of 10
M TAC on the amplitude of the cold-evoked response. One-way ANOVA for repeated measures followed by Bonferroni’s post hoc test. H, Time course of fura-2 ratio in a YFP(), which was not activated in
control conditions (i.e., cold insensitive) but was recruited in the presence of 10M TAC. I, Temperature threshold of individual YFP() neurons to cold or cold plus 10M TAC. The mean temperature threshold
(red triangles) shifted from 23.9  0.9°C in control solution to 27.8  0.8°C in the presence of 10 M TAC ( p 
 0.001, n  14, paired Student’s t test). **p 
 0.01, ***p 
 0.001.
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activated by cold (36 of 37), but only 1 in 130 YFP() was
cold-sensitive, suggesting a very good match between YFP flu-
orescence and TRPM8 expression (Fig. 7 B, C).
Application of 30 M TAC activated the majority of TRPM8-
expressing thermoreceptor neurons (31 of 36), identified by the
expression of YFP and by their response to a cold temperature
ramp (Fig. 7A,C). In the presence of 30 M TAC, the amplitude
of cold-evoked responses also increased significantly in YFP()
neurons (Fig. 7D). TAC and cold produced a similar activation of
individual neurons, and the amplitude of both responses was
strongly correlated (r 2  0.42) (Fig. 7E). In contrast, none (0 of
130) of the YFP() neurons (i.e., those not expressing TRPM8)
were activated by 30 M TAC, although they showed normal
responses to 30 mM KCl (data not shown).
We also examined the effects of lower concentration of TAC
on DRG neurons. As shown in Figure 7F, at 10 M, the effects of
TAC on [Ca 2] levels on a YFP() neuron were negligible. How-
ever, we found that this concentration of TAC sensitized the re-
sponse of TRPM8-expressing neurons to cold in a reversible
manner. This is a similar effect to that described for other chem-
ical agonists of TRPM8 (McKemy et al., 2002; Voets et al., 2004).
On average, the [Ca 2] response to cold increased from 0.41 
0.07 during the first cold ramp to 0.57  0.06 during a second
cold ramp, in the presence of TAC (p 
 0.01, n  14) (Fig. 7G).
The larger amplitude in the cold-evoked response was accompa-
nied by a shift in the response threshold of individual neurons
toward warmer temperatures (Fig. 7F, I). On average, the thresh-
old shifted by 	4°C, from a mean of 23.8  0.9°C in control to
27.8  0.7°C in the presence of 10 M TAC (p 
 0.001, n  14).
In addition, one YFP() neuron initially insensitive to cold be-
came cold sensitive during the application of this TAC concen-
tration, and this activation was reversible (Fig. 7H).
In agreement with the observations obtained in TRPM8-
transfected HEK293 cells, cyclosporine (30 M) failed to activate
YFP() DRG neurons (0 of 37), or sensitize their responses to
cold: the increase in cold-evoked fura-2 ratio was 0.72  0.13 in
the presence of vehicle (n  16), compared with 0.63  0.06 in
the presence of cyclosporine (n  37) (p  0.40, unpaired Stu-
dent’s t test).
Collectively, these results indicate that TAC excites cold-
sensitive neurons that express TRPM8, and potentiates their cold
response by shifting the threshold temperature to warmer
temperatures.
TRPM8 mediates TAC responses in DRG neurons
Next, we explored whether TAC responses in cold-sensitive DRG
neurons were mediated by TRPM8 activation. To this end, we
combined two experimental strategies: a pharmacological ap-
proach using two different TRPM8 blockers and a genetic ap-
proximation, characterizing responses in TRPM8 KO mice. If
TAC responses were mediated by TRPM8 activation, they should
be sensitive to TRPM8 antagonists. As shown in Figure 8A, B, this
prediction was fulfilled; the responses to TAC in cold-sensitive
DRG neurons were completely blocked by AMTB (10 M) and
BCTC (50 M), two structurally unrelated TRPM8 antagonists
(Almaraz et al., 2014). A summary of these results is shown in
Figures 8C, D. Moreover, the [Ca 2]i elevation during cold
ramps in the presence of TAC were also greatly reduced by these
two antagonists (p 
 0.001).
To confirm the effects of TAC on native TRPM8 channels, we
examined responses to TAC in DRG cultures from a transgenic
mouse line in which a farnesylated eGFP is expressed from the
Trpm8 locus (TRPM8EGFPf) in replacement of TRPM8, allowing
the identification of putative TRPM8-expressing neurons
Figure 8. TRPM8 antagonists block the excitatory effects of TAC on mice DRG neurons. A, Ratiometric [Ca 2] levels in a fura-2 AM-loaded cultured DRG neuron from a Trpm8 BAC-EYFP mouse,
showing the response to cold and TAC in control conditions and in the presence of the TRPM8 blocker AMTB (10 M). B, A similar protocol in the presence of BCTC (50 M), a different, structurally
unrelated, TRPM8 blocker. C, Bar histograms summarizing the effects of AMTB (n  16), and (D) BCTC (n  15) on cold- and TAC-evoked responses. Statistical differences evaluated with one-way
ANOVA followed by Bonferroni post hoc test. *p 
 0.05, ***p 
 0.001.
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(Dhaka et al., 2007). We compared responses in cultures from
Trpm8EGFPf/ mice, which maintain one copy of TRPM8, with
those in Trpm8EGFPf/EGFPf animals, thus null for TRPM8.
In Trpm8EGFPf/ DRG cultures, 13% (67 of 515) of the neu-
rons were fluorescent and practically all of them (66 of 67) were
activated by cold or menthol, consistent with their expression of
TRPM8 (Fig. 9A). Moreover, approximately half of the green
fluorescent neurons were activated by TAC (35 of 67). In the
presence of TAC, or menthol, cold responses were potentiated
(Fig. 9A, green trace), consistent with an effect on TRPM8. The
phenotype of GFP() neurons was very different: very few
(2.4%) were cold-sensitive, and only 2.7% (12 of 448) were acti-
vated by TAC (Fig. 9A, red trace), a significantly lower percentage
(p 
 0.001, Z test). A Venn diagram of these results is shown in
Figure 9B. In summary, in agreement with the results observed in
Trpm8 BAC-EYFP mice, there is a high correlation between ex-
pression of TRPM8 and responses to TAC.
The responses to TAC in Trpm8EGFPf/EGFPf (i.e., Trpm8 KO)
mice were very infrequent, albeit detectable in some neurons
(Fig. 9C, pink trace). In total, only 13 of 516 (2.9%) DRG neurons
responded to 30 M TAC in Trpm8 KO animals (4 were GFP()
and 9 were GFP()). The main reduction occurred in GFP()
neurons, in parallel with a near suppression of their responses to
cold or menthol (Fig. 9C, green trace). As summarized in Figure
9D, of 70 GFP() neurons tested, only 4 (5.7%) responded to
TAC, a drastic reduction from the responses observed in GFP()
neurons in Trpm8EGFPf/ mice (p 
 0.001, Z test). Figure 9E
summarizes the responses to TAC and cold in fluorescent and
nonfluorescent cells of the two transgenic mouse lines. It is evi-
dent that expression of TRPM8 is highly correlated with re-
sponses to TAC.
Finally, in GFP() neurons of Trpm8EGFPf/EGFPf mice, only
2% (9 of 446) responded to TAC, a very similar percentage to that
observed in GFP() neurons of Trpm8EGFPf/ mice. The re-
sponses to TAC in GFP() neurons had some distinct character-
istics: because the results were similar in Trpm8EGFPf/ and
Trpm8EGFPf/EGFPf animals, we pooled them together. In GFP()
neurons, the amplitude of TAC responses was smaller (p 

Figure 9. TRPM8 is the principal mediator of the excitatory effects of TAC on DRG neurons. A, Representative traces of fura-2 ratio fluorescence in a Trpm8EGFPf/ DRG culture. Consecutive
applications of cold, TAC (30 M), menthol (100 M), AITC (100 M), capsaicin (100 nM), and high K  (30 mM) were used to define the phenotype of each neuron. The GFP() neuron (green trace)
is activated by cold, TAC, and menthol. A GFP() neuron (red trace) is not activated by cold or menthol but shows a small response to TAC; typically, these neurons are activated by capsaicin. B, Venn
diagram summarizing the responses to TAC in GFP() and GFP() neurons in Trpm8EGFPf/ mice. C, Representative traces of fura-2 ratio fluorescence in cultured DRG neurons from a Trpm8 KO
mouse. Same protocol as in A. Note the inhibition of the small TAC response by cooling in a GFP() neuron (pink trace). A GFP() neuron (green trace) does not respond to cold or menthol but
responds to capsaicin. D, Venn diagram summarizing the responses to TAC in GFP() and GFP() neurons in Trpm8 KO mice. E, Summary of responses (in percentage of total neurons) to cold, TAC,
and TAC plus cold in Trpm8 BAC-EYFP, Trpm8EGFPf/, and Trpm8EGFPf/EGFPf mice. For each mouse line, neurons have been separated as fluorescent or nonfluorescent. F, Mean amplitude of TAC
responses in fluorescent (TRPM8 BAC-EYFP and Trpm8EGFPf/) and nonfluorescent neurons (Trpm8EGFPf/ and Trpm8EGFPf/EGFPf). Differences in amplitude between fluorescent and nonfluorescent
neurons were statistically significant (one-way ANOVA). *p 
 0.05, **p 
 0.01.
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0.001) compared with responses in fluorescent neurons of
Trpm8EGFPf/ mice or Trpm8 BAC-EYFP mice (Fig. 9F), and they
were nearly abolished during the cooling ramp (Fig. 9A,C). None
of these neurons was cold-sensitive (Fig. 9A, red trace). Interest-
ingly, of the 21 GFP() neurons activated by TAC, 18 also re-
sponded to capsaicin (100 nM) and 11 responded to AITC (50
M). These characteristics are consistent with a possible effect of
TAC on TRPV1. However, we note that in these cultures 43.8%
(452 of 1031) of the neurons responded to capsaicin, but only 22
of these 452 (4.9%) responded to TAC.
Together, the results obtained with pharmacological block-
ers and after genetic inactivation of TRPM8 indicate that the
main excitatory action of TAC in DRG neurons is mediated by
activation of TRPM8 channels in cold-sensitive neurons, with
some weaker effects on capsaicin-sensitive neurons, presum-
ably though TRPV1.
TAC activates inward currents and elicit AP firing in
cold thermoreceptors
The effect of TAC on the excitability of cold thermoreceptors was
further evaluated by performing electrophysiological recordings
in cultured DRG neurons from Trpm8 BAC-EYFP mice. As shown
in Figure 10A, in whole-cell patch-clamp recordings, TAC (30
M) activated an inward current and potentiated the currents
evoked by cold temperature in all the YFP() neurons tested.
This potentiation was accompanied by a clear shift in the activa-
tion of cold-evoked currents to warmer temperatures (Fig. 10B).
In the same neurons, application of menthol (30 M) produced
similar effects to TAC, although its potentiating effect on cold-
evoked currents was stronger. A summary of these results is
shown in Figure 10C.
Recordings in the current-clamp configuration of TRPM8-
expressing cold thermoreceptors, at a holding temperature of
33°C, showed that TAC application induced the firing of action
potentials and strongly potentiated cold-evoked firing (Fig. 10D).
These results are summarized in Figure 10E.
These data confirm that TAC activates a depolarizing inward
current similar to the TRPM8-dependent ICold current, increas-
ing the excitability of cold-sensitive neurons.
TAC activates cold-sensitive corneal afferents
The corneal surface is densely innervated by cold-sensitive nerve
endings that express TRPM8 channels (Parra et al., 2010; Alamri
et al., 2018; Alcalde et al., 2018). We used extracellular recordings
of these terminals in a mouse in vitro preparation to investigate
the effects of TAC on sensory nerve endings.
Corneal cold-sensitive nerve endings are characterized by
their spontaneous, low-frequency, background activity at 34°C
with a sharp increase in firing rate, often organized in the form of
bursts, during cooling (Fig. 11A,C) (Carr et al., 2003; Parra et al.,
Figure 10. TAC increases the excitability of cold-sensitive DRG neurons. A, Representative whole-cell recording in the voltage-clamp configuration (Vhold  60 mV) of a TRPM8-expressing,
cold-sensitive DRG neuron identified by the expression of EYFP. TAC (30 M) evoked an inward current similar in amplitude to that elicited by menthol (30 M). Both TAC and menthol strongly
potentiate the response to cold. Bottom, Simultaneous recording of bath temperature during the recording. B, Current-temperature relationships for the same neuron in control (black trace) and in
the presence of 30 M TAC (red trace) or 30 M menthol (green trace). Note the marked shift in temperature threshold. C, Bar histogram summarizing the effects of agonists on the amplitude of
inward currents during the protocol shown in A. The statistical analysis consisted of a one-way ANOVA followed by Bonferroni’s post hoc test (*p 
 0.05, **p 
 0.01). D, Representative recording
of a cold-sensitive DRG neuron in the whole-cell current-clamp configuration showing responses to cold and to the application of TAC (30 M). TAC evoked AP firing at 33°C and greatly enhanced
the firing frequency during a cold ramp. Bottom, Simultaneous recording of bath temperature. E, Bar histogram summarizing the mean responses, measured as average firing frequency, during the
different stimuli applied. Firing frequency for cold was averaged from the first to the last spike during the cooling ramp. Firing frequency in control condition was calculated during the minute
preceding TAC application (only 3 of 7 neurons fired action potentials in control conditions). TAC-evoked firing was calculated from the first spike during TAC application to the start of the cold ramp.
The analysis consisted of a paired t test for cold versus TAC plus cold (**p  0.009) and control vs TAC (*p  0.048).
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Figure 11. TAC activates corneal cold thermoreceptor endings. A, Representative example of nerve terminal impulses recorded from a mouse corneal ending in control solution, at three different
temperatures. B, Recordings from the same ending during application of 30 M TAC. C, Instantaneous firing frequency from the same ending as in A (control solution), and D, as in B (in TAC). Note
the regular firing in bursts during cooling. E, Summary of the effects of 30 M TAC on spontaneous firing in 7 individual endings at the basal temperature of 34°C. The increase in firing was statistically
significant (***p 
 0.001, paired Student’s t test). F, Mean firing rate in TAC at three different temperatures in 7 cold thermoreceptor endings. Activity at each temperature has been normalized to
the value obtained in control solution. Statistical differences evaluated by one-way ANOVA for repeated measures followed by Bonferroni post hoc test. (*p 
 0.05, ***p 
 0.001.)
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2010; Orio et al., 2012). At a baseline temperature of 34°C, expo-
sure to 30 M TAC produced clear excitatory effects (Fig. 11B,D,
left), with an increase in the basal firing rate, from 5.8  0.8 Hz in
control to 10.2  1.6 Hz in TAC (n  7, p 
 0.001; paired
Student’s t test). The firing rate increases during cooling in the
presence of TAC (Fig. 11B–D, middle, right). Figure 11E shows a
summary of the effects of TAC on basal firing rate for individual
cold-sensitive endings at 34°C. The excitatory effect of TAC was
also evident on the steady-state firing rate at lower temperatures,
with an elevation in mean firing frequency and the increase in the
number of spikes per burst (Fig. 11B). The potentiation of activ-
ity mediated by TAC at the different temperatures is shown in
Figure 11F. The washout of TAC effects was only partial, proba-
bly explained by the long application times required to examine
the effects of TAC at different temperatures and the lipophilic
nature of the compound (Fig. 11E).
These results show that the excitatory effects of TAC on cold
thermoreceptor activity are maintained at peripheral nerve end-
ings, the physiological site for chemotransduction and thermo-
transduction in these neurons.
TAC sensitizes cutaneous cold thermoreceptors
To further characterize the effects of TAC on cold thermorecep-
tor endings, we used a mouse skin-nerve preparation. We focused
our efforts on unimodal cutaneous cold receptors (i.e., cold-
activated fibers insensitive to mechanical stimuli) because it is
well known that TRPM8 plays an essential role in their cold-
evoked activity (Toro et al., 2015; Winter et al., 2017). We iden-
tified 9 fibers in the saphenous nerve with the aforesaid
characteristics. These fibers were silent at the baseline tempera-
ture of 34°C–35°C but were activated when cold solution was
delivered to their isolated receptive field (Fig. 12A,B), with a
mean cold threshold of 30.4  1°C (n  9) (Fig. 12C). During
application of TAC (30 M), none of the fibers presented activity
at the basal temperature of 34°C. However, their cold-evoked
activity was clearly modified in the presence of TAC (Fig. 12A,B).
In 6 of these 9 fibers, TAC shifted their cold threshold to warmer
temperatures (mean temperature threshold displacement of
2.1  0.5°C, n  9) and shifted their stimulus response function
to warmer temperatures (Fig. 12C). As in the cornea, the washout
of TAC effects was only partial (Fig. 12B,C). In these endings,
menthol (50 M) produced qualitatively similar excitatory ef-
fects, although more intense. Thus, menthol produced an in-
crease in spontaneous activity at the basal temperature of
34°C–35°C in 5 of 9 endings tested (Fig. 12B). In addition, men-
thol shifted their temperature threshold, by at least 1°C, to
warmer values in all of them (n  9). The mean temperature
threshold displacement produced by menthol was 3.3  0.7°C
(Fig. 12C), and their overall firing was more pronounced and
shifted to warmer temperatures (Fig. 12D). Collectively, these
results indicate that TAC sensitizes a population of cutaneous
TRPM8-expressing thermoreceptor endings to cold tempera-
ture.
TAC evokes TRPM8-dependent cold hypersensitivity
Agonists of TRPM8 channels can lead to cold-evoked avoidance
behaviors (Rossi et al., 2006; Klein et al., 2010). Thus, we exam-
ined the possible influence of TAC on cold-evoked behaviors in
mice. In adult WT mice, intraplantar injection of 1% TAC de-
creased the latency of paw withdrawal from a cold plate set at
10°C. The reduction was significant (p 
 0.01, one-way
ANOVA) compared with the injection of vehicle or the latency
observed in naive paws (Fig. 13A, left). Injection of 1% menthol,
the canonical agonist of TRPM8 channels, also caused a signifi-
cant reduction in withdrawal latency (Fig. 13A). To test for the
role of TRPM8 in the cold hypersensitivity produced by TAC, we
examined the withdrawal latency in Trpm8 KO mice. As shown in
Figure 13A (right), in these mice, TAC failed to sensitize their
response to cold (one-way ANOVA), and their withdrawal la-
tency was significantly longer compared with results obtained in
WT (p 
 0.01, unpaired t test).
These results confirm the role of TRPM8 channels in the cold
hypersensitivity produced by TAC at peripheral nerve endings.
TAC triggers tearing and blinking
Afferent discharge from different classes of corneal sensory fibers,
including cold receptors and polymodal nociceptors, participates
in the neural mechanisms of basal and reflex-evoked tearing (Bel-
monte and Gallar, 2011; Meng and Kurose, 2013). We examined
the effect of TAC solutions on tearing in anesthetized WT mice.
We applied, sequentially, a small drop of saline, vehicle, or TAC
(1%) to both eyes and measured the tearing after a rest period of
5 min. As shown in Figure 13B, TAC produced a significant in-
crease in tearing compared with saline (p 
 0.01) or vehicle (p 

0.05; one-way ANOVA). To control for possible sensitization
effects produced by repeated applications of solutions to the cor-
neal surface, we designed a control experiment, consisting of 3
consecutive applications of saline, which resulted in very similar
mean values of tearing for each of them (Fig. 13C).
A previous study identified the critical role of TRPM8 chan-
nels in eye blinking in mice following application of hyperosmo-
lar solutions (Quallo et al., 2015). Thus, we decided to investigate
the effects of TAC solutions applied to the corneal surface. We
counted the number of blinks observed after unilateral applica-
tion of solutions with 1% TAC to the eyes of WT (n  8) and
Trpm8/ mice (n  17). Application of saline (315 mOsm/kg)
or vehicle had only a small effect on blinking. In contrast, as
shown in Figure 13D (left), 1% TAC triggered a large increase in
the number of blinks in WT mice. In agreement with previous
findings (Quallo et al., 2015), hyperosmotic solutions (785
mOsm/kg) also triggered a marked increase in eye blinking, sim-
ilar to that observed with TAC.
Repeating the tests in Trpm8 KO mice confirmed a reduction
in blinking, compared with WT (p 
 0.01, unpaired t test), pro-
duced by hyperosmolar solutions reported previously. In con-
trast, the blinks produced by 1% TAC in Trpm8 KO mice were
very variable, but they were not different from those observed in
WT mice (Fig. 13D, right). These results suggest that 1% TAC has
effects on blinking that are in independent of TRPM8 activity.
Discussion
Natural products remain an important source for the develop-
ment of pharmaceutical drugs (Newman and Cragg, 2016), and
have also played a fundamental role in the discovery and charac-
terization of TRP channels (Julius, 2005; Nilius and Appendino,
2011; Meotti et al., 2014). However, despite major drug discovery
efforts, the number of chemical agonists reported for TRPM8
channels is still very modest (Bödding et al., 2007; Almaraz et al.,
2014; LeGay et al., 2016; Moran and Szallasi, 2018). Moreover,
many of these agonists show cross-sensitivity with other TRP
channels (Macpherson et al., 2006). We have identified TAC, a
clinically relevant macrolide immunosuppressant produced by
soil microorganisms, as a novel agonist of TRPM8 channels.
These findings highlight a novel neuroimmune interface in pe-
ripheral tissues with several potential applications. First, it ex-
pands the current arsenal of drugs targeting TRPM8 and provides
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new clues about its activation mechanism. Second, the effects of
TAC on TRPM8 could be used as an experimental tool to inves-
tigate the functional activity of this polymodal ion channel in
humans, for example, as a new surrogate model of cold allodynia
and hyperalgesia (Andersen et al., 2014).
In contrast to TAC, cyclosporine, a cyclic undecapeptide also
targeting calcineurin signaling, had no effect on TRPM8 or cold-
evoked responses in DRG neurons. This result excludes this path-
way as the one involved in the effects of TAC. Moreover, the
activation of reconstituted TRPM8 by TAC in planar lipid bilay-
Figure 12. TAC activates cutaneous cold thermoreceptors. A, Representative recording showing the response of a cold fiber to a decrease in the temperature of the isolated receptive field, before
and after treatment with 30 M TAC. Top to bottom, Instantaneous firing frequency, the voltage signal, and the temperature of the receptive field. B, Histogram showing the averaged cold-evoked
response of cold fibers from C57BL/6J mice in control solution (black triangles), in the presence of 30 M TAC (orange circles), and in 50 M menthol (green squares). Average discharge rates are
represented in bins of 2 s. Bottom, The temperature ramp for each of the datasets. C, Temperature threshold for activation of impulse discharge. D, Temperature for reaching the maximal discharge
rate. Squares represent mean values. Boxes represent SEM. Error bars indicate standard deviation (SD). In C and D, *p 
 0.05, **p 
 0.01, ***p 
 0.001 (one-way ANOVA with Bonferroni’s post
hoc correction). The asterisks compare significance with respect to cold. The #( p 
 0.05) compares significance with respect to wash.
Arcas et al. • Immunosuppressant Activation of TRPM8 J. Neurosci., February 6, 2019 • 39(6):949 –969 • 965
Figure 13. TAC sensitizes cold-evoked responses and triggers eye blinking and tearing. A, Withdrawal latencies for hindpaws placed in contact with a cold metal plate set at 10°C. Individual and
mean  SEM values in WT (filled bars) mice for different conditions: naive mice, after the injection of vehicle, 1% menthol, and 1% TAC. Right, Open bars represent the same experiment in Trpm8
KO mice. Differences with respect to naive (*), to vehicle (#) (one-way ANOVA followed by Bonferroni’s post hoc test). TAC reduces the withdrawal latency in WT mice compared with Trpm8 KO.
&&p 
 0.01 (unpaired Student’s t test). B, Effects of different topical solutions on basal tearing in mice. The left and the right eye received 2 l of saline, vehicle (8% ethanol, 2% Cremophor in saline)
or TAC (1%). Tearing was estimated from the length of staining in the threads. The effect of TAC was significant with respect to saline (**p 
 0.01) or vehicle (*p 
 0.05) (n  10 mice; one-way
ANOVA). C, Three consecutive applications of saline were used as a control (n  5 mice). No increment in tearing was observed in this case (one-way ANOVA). D, Effects of different topical solutions
(5 l) on eye blinking, monitored over a 2 min period, in WT mice (filled bars; n  8). Compared with saline (*) and vehicle (#) (see above), 1% TAC and hyperosmotic (785 mOsm/kg) solution
increased the number of blinks (***p 
 0.001. ##p 
 0.01). In Trpm8 KO mice (open bars; n  17), TAC increased the number of blinks with respect to saline (***p 
 0.001) or the TAC vehicle
( ###p 
 0.001), and Hyp increased the blinks with respect to saline (**p 
 0.001) (one-way ANOVA followed by Bonferroni’s post hoc test). The number of blinks to Hyp were significantly reduced
in Trpm8 KO mice compared with WT. &&p 
 0.01 (unpaired Student’s t test).
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ers conclusively demonstrates that the interaction of TAC with
the channel is direct and does not require signaling cascades.
Similarly to the activation by cold and menthol, the gating of
TRPM8 by TAC depended specifically on the presence of
PI(4,5)P2 (Zakharian et al., 2010).
Biophysical and molecular aspects of TAC agonism
on TRPM8
In many aspects, the activation of TRPM8 by TAC resembles the
effects of menthol on channel gating: TAC shifts the activation
threshold of TRPM8 to higher temperatures and slows the acti-
vation kinetics. These characteristics fit with the description of
Type I agonists introduced by Janssens et al. (2016), which in-
clude menthol, thymol, icilin, and linalool. Interestingly, the ef-
fects of TAC persisted in a menthol-insensitive mutant. Our
previous characterization of antagonist effects on TRPM8 sug-
gested a sequential model of TRPM8 gating where chemical
modulators can favor (e.g., menthol) or hinder (e.g., BCTC or
SKF96365) the energetics of subsequent channel opening by cold
temperature or voltage from different binding sites (Mälkiä et al.,
2009). This model is consistent with the actions of TAC, having
an excitatory action on the menthol-insensitive Y745H mutant,
but failing to facilitate the gating by cold temperature, suggesting
that the actions of different chemical agonists converge from in-
dependent binding sites.
The identification of the residues critical for TAC effects
should be addressed in the future; we excluded its interaction
with the icilin and menthol binding sites. The recent cryostruc-
ture of the TRPM8 tetramer could facilitate their identification
(Yin et al., 2018).
Specificity of TAC effects
Based on the pharmacological characterization in WT, hemizy-
gous, and Trpm8 null mice, we conclude that the effects of TAC
on TRPM8-expressing sensory neurons is highly selective. How-
ever, this specificity is not absolute. In cultured neurons of Trpm8
KO mice, a small effect of TAC remains that is likely mediated by
TRPV1. A previous study found that TAC activated a small per-
centage (3.1%) of rat DRG neurons, and many of these neurons
were also activated by capsaicin (Senba et al., 2004). As in our
case, and consistent with a weak effect, the percentage of
capsaicin-positive neurons was much higher than those respond-
ing to TAC. Surprisingly, we did not observe any effects of TAC
on recombinant TRPV1 channels. In contrast, TAC also activated
TRPA1 expressed heterologously, albeit less affectively than
TRPM8.
The behavioral results indicate that the cold hypersensitivity
produced by TAC is clearly mediated by TRPM8. The stronger
effects of TAC compared with menthol, opposite to the effects
observed in vitro, may be explained by its actions on other ion
channels (Swandulla et al., 1987). Moreover, it is well known that
high concentrations of topical menthol, as used here, are analge-
sic (Liu et al., 2013). A reported side effect of TAC treatment is the
experience of chills. They could be caused by activation of
TRPM8 because it is an effect observed with other TRPM8 ago-
nists (e.g., icilin), and linked to the role of the channel in thermo-
regulation (Knowlton et al., 2011; Pogorzala et al., 2013;
Reimúndez et al., 2018).
Topical applications of 1% TAC solutions also increased basal
tearing and triggered eye blinking. However, in this last case, the
effects were not reduced in TRPM8 KO mice. This result suggests
that this solution has irritant effects that are independent of
TRPM8 activation. Because topical TAC formulations have
much higher concentrations of the drug than we could test in
solution in vitro, it could lead to activation of other nociceptive
TRP channels, explaining the transient burning sensation re-
ported upon topical application of TAC to the eye (Fukushima et
al., 2014; Abud et al., 2016) and the skin. These irritant actions are
the most common side effect associated with topical application
of TAC. Consistent with a possible activation of TRPA1, in a
murine model of chronic contact hypersensitivity, TAC in-
creased the number of scratch bouts, and these were significantly
reduced by topical application of a TRPA1 antagonist (Wong et
al., 2018). Alternatively, because a subpopulation of TRPM8-
expressing primary sensory neurons have a nociceptive pheno-
type (Xing et al., 2006; Alcalde et al., 2018), and many also express
TRPV1, their activation may contribute to the transient discom-
fort produced by TAC.
Therapeutic implications
TRPM8 plays a multifaceted role in cold-related pain. On one
hand, it appears to participate in the mechanisms of cold hyper-
algesia and allodynia (Knowlton et al., 2013). At the same time, it
is the principal mechanism of menthol-induced analgesia (Liu et
al., 2013), and also plays a significant role in cooling-mediated
analgesia (Proudfoot et al., 2006; Knowlton et al., 2013). Activa-
tion of TRPM8 sensory pathways also reliefs the sensation of itch
(Palkar et al., 2018). Moreover, TRPM8 activation has a potent
anti-inflammatory role in the gut (Ramachandran et al., 2013).
Therefore, TRPM8 modulators (agonists and antagonists) may
offer multiple possibilities in the relief of pain and visceral in-
flammation (Pérez de Vega et al., 2016; Moran and Szallasi,
2018).
Because activation of TRPM8 regulates basal tearing and
blinking (Parra et al., 2010; Quallo et al., 2015), it has been pro-
posed as a possible therapy for DED (Parra et al., 2010; Belmonte
and Gallar, 2011). In addition to its use as a systemic immuno-
suppressant in the prevention of organ rejection, TAC is also used
topically in the treatment of DED symptoms (Jones et al., 2017).
In clinical ophthalmology, TAC has been used in solutions at
concentrations up to 0.1%. This is equivalent to 1.2 mM, suggest-
ing that it should readily activate TRPM8 channels at corneal
endings. We observed a clear effect of 1% TAC solutions on basal
tearing and eye blinking, suggesting that some of the beneficial
effects reported for TAC in dry-eye conditions (Abud et al., 2016)
may involve activation of TRPM8 channels in trigeminal cold
thermoreceptor endings. However, the fact that blinking was not
reduced in TRPM8 null mice clearly indicates that other mecha-
nisms are involved at this concentration and with this particular
formulation. The activation of TRPA1, and possibly TRPV1, at
these high concentrations of TAC could also explain the burning
sensation reported by some patients.
We also show that TAC activates cutaneous cold thermore-
ceptor endings and sensitizes responses to cold temperature. The
apparent potency was lower than for corneal endings. This, how-
ever, may reflect a poor accessibility of the drug in the in vitro
preparation we used, which lacks vascularization and requires
application of substances through the corium. Whether activa-
tion of TRPM8 by TAC is relevant for the treatment of atopic
dermatitis is currently unclear. Nevertheless, it is becoming well
established that electrical activity in peripheral sensory endings
can have potent immunomodulatory effects (Chavan et al.,
2017), suggesting that modulation of TRPM8 channels by TAC
may play a role in its anti-inflammatory actions. At this point, this
is just a hypothesis but with important implications.
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In conclusion, we report the activation of cold-activated
TRPM8 channels by the natural immunosuppressant TAC. The
speed of the effect and the action on reconstituted channels make
it incompatible with transcriptional actions. Biophysically, the
effects of TAC on TRPM8 gating resemble those of menthol,
although mutagenesis studies suggest and independent binding
site.
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Bödding M, Wissenbach U, Flockerzi V (2007) Characterisation of TRPM8
as a pharmacophore receptor. Cell Calcium 42:618 – 628. CrossRef
Medline
Brauchi S, Orio P, Latorre R (2004) Clues to understanding cold sensation:
thermodynamics and electrophysiological analysis of the cold receptor
TRPM8. Proc Natl Acad Sci U S A 101:15494 –15499. CrossRef Medline
Carr RW, Pianova S, Fernandez J, Fallon JB, Belmonte C, Brock JA (2003)
Effects of heating and cooling on nerve terminal impulses recorded from
cold-sensitive receptors in the guinea-pig cornea. J Gen Physiol 121:427–
439. CrossRef Medline
Chavan SS, Pavlov VA, Tracey KJ (2017) Mechanisms and therapeutic rel-
evance of neuro-immune communication. Immunity 46:927–942.
CrossRef Medline
Chuang HH, Neuhausser WM, Julius D (2004) The super-cooling agent
icilin reveals a mechanism of coincidence detection by a temperature-
sensitive TRP channel. Neuron. 43:859 – 869. CrossRef Medline
Dhaka A, Viswanath V, Patapoutian A (2006) Trp ion channels and temper-
ature sensation. Annu Rev Neurosci 29:135–161. CrossRef Medline
Dhaka A, Murray AN, Mathur J, Earley TJ, Petrus MJ, Patapoutian A (2007)
TRPM8 is required for cold sensation in mice. Neuron 54:371–378.
CrossRef Medline
Dhaka A, Earley TJ, Watson J, Patapoutian A (2008) Visualizing cold spots:
TRPM8-expressing sensory neurons and their projections. J Neurosci
28:566 –575. CrossRef Medline
Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, Kumagai N, Shoji J,
Takamura E, Nakagawa Y, Namba K, Fujishima H, Miyazaki D (2014)
Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic
ocular diseases with proliferative lesion or corneal involvement. Br J Oph-
thalmol 98:1023–1027. CrossRef Medline
González-González O, Bech F, Gallar J, Merayo-Lloves J, Belmonte C (2017)
Functional Properties of Sensory Nerve Terminals of the Mouse Cornea.
Invest Ophthalmol Vis Sci. 58:404 – 415. CrossRef
Janssens A, Gees M, Toth BI, Ghosh D, Mulier M, Vennekens R, Vriens J,
Talavera K, Voets T (2016) Definition of two agonist types at the mam-
malian cold-activated channel TRPM8. Elife 5:e17240. CrossRef Medline
Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX,
Dong PN, Geerling G, Hida RY, Liu Y, Seo KY, Tauber J, Wakamatsu TH,
Xu J, Wolffsohn JS, Craig JP (2017) TFOS DEWS II management and
therapy report. Ocul Surf 15:575– 628. CrossRef Medline
Julius D (2005) From peppers to peppermints: natural products as probes of
the pain pathway. Harvey Lect 101:89 –115. Medline
Klein AH, Sawyer CM, Carstens MI, Tsagareli MG, Tsiklauri N, Carstens E
(2010) Topical application of L-menthol induces heat analgesia, me-
chanical allodynia, and a biphasic effect on cold sensitivity in rats. Behav
Brain Res 212:179 –186. CrossRef Medline
Knowlton WM, Daniels RL, Palkar R, McCoy DD, McKemy DD (2011)
Pharmacological blockade of TRPM8 ion channels alters cold and cold
pain responses in mice. PLoS One 6:e25894. CrossRef Medline
Knowlton WM, Palkar R, Lippoldt EK, McCoy DD, Baluch F, Chen J, McK-
emy DD (2013) A sensory-labeled line for cold: TRPM8-expressing sen-
sory neurons define the cellular basis for cold, cold pain, and cooling-
mediated analgesia. J Neurosci 33:2837–2848. CrossRef Medline
LeGay CM, Gorobets E, Iftinca M, Ramachandran R, Altier C, Derksen DJ
(2016) Natural-product-derived transient receptor potential melastatin
8 (TRPM8) channel modulators. Org Lett 18:2746 –2749. CrossRef
Medline
Liu B, Qin F (2005) Functional control of cold- and menthol-sensitive
TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. J Neuro-
sci 25:1674 –1681. CrossRef Medline
Liu B, Fan L, Balakrishna S, Sui A, Morris JB, Jordt SE (2013) TRPM8 is the
principal mediator of menthol-induced analgesia of acute and inflamma-
tory pain. Pain 154:2169 –2177. CrossRef Medline
Macpherson LJ, Hwang SW, Miyamoto T, Dubin AE, Patapoutian A, Story
GM (2006) More than cool: promiscuous relationships of menthol and
other sensory compounds. Mol Cell Neurosci 32:335–343. CrossRef
Medline
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Pérez de Vega MJ, Gómez-Monterrey I, Ferrer-Montiel A, González-MuñizR
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Swandulla D, Carbone E, Schäfer K, Lux HD (1987) Effect of menthol on
two types of Ca currents in cultured sensory neurons of vertebrates.
Pflugers Arch 409:52–59. CrossRef Medline
Takashima Y, Daniels RL, Knowlton W, Teng J, Liman ER, McKemy DD
(2007) Diversity in the neural circuitry of cold sensing revealed by ge-
netic axonal labeling of transient receptor potential melastatin 8 neurons.
J Neurosci 27:14147–14157. CrossRef Medline
Toro CA, Eger S, Veliz L, Sotelo-Hitschfeld P, Cabezas D, Castro MA, Zim-
mermann K, Brauchi S (2015) Agonist-dependent modulation of cell
surface expression of the cold receptor TRPM8. J Neurosci 35:571–582.
CrossRef Medline
Voets T, Droogmans G, Wissenbach U, Janssens A, Flockerzi V, Nilius B
(2004) The principle of temperature-dependent gating in cold- and heat-
sensitive TRP channels. Nature 430:748 –754. CrossRef Medline
Wan XC, Dimov V (2014) Pharmacokinetic evaluation of topical calcineu-
rin inhibitors for treatment of allergic conjunctivitis. Expert Opin Drug
Metab Toxicol 10:543–549. CrossRef Medline
Winter Z, Gruschwitz P, Eger S, Touska F, Zimmermann K (2017) Cold
temperature encoding by cutaneous TRPA1 and TRPM8-carrying fibers
in the mouse. Front Mol Neurosci 10:209. CrossRef Medline
Wong LS, Otsuka A, Yamamoto Y, Nonomura Y, Nakashima C, Kitayama N,
Usui K, Honda T, Kabashima K (2018) TRPA1 channel participates in
tacrolimus-induced pruritus in a chronic contact hypersensitivity murine
model. J Dermatol Sci 89:207–209. CrossRef Medline
Xing H, Ling J, Chen M, Gu JG (2006) Chemical and cold sensitivity of two
distinct populations of TRPM8-expressing somatosensory neurons.
J Neurophysiol 95:1221–1230. CrossRef Medline
Yin Y, Wu M, Zubcevic L, Borschel WF, Lander GC, Lee SY (2018) Structure
of the cold- and menthol-sensing ion channel TRPM8. Science 359:237–
241. CrossRef Medline
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